针对癌症治疗的蛋白质稳定路径
Xiaofeng Dai1, Ruohan Lyu2, Guanqun Ge3
1National Local Joint Engineering Research Center for Precision Surgery & Regenerative Medicine, Shaanxi Provincial Center for Regenerative Medicine and Surgical Engineering, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, 710061, China.
Journal of pharmaceutical analysis
|December 11, 2025
概括
热冲击蛋白90 (HSP90) 抑制显示了通过向蛋白质稳定性来治疗癌症的前景. 冷大气等离子体 (CAP) 提供了一个更安全的替代方案,可能治疗与炎症相关的癌症和自身免疫性疾病.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 蛋白质平衡 (蛋白质平衡) 对于预防癌症发展至关重要.
- 热冲击蛋白90 (HSP90) 抑制剂正在研究用于癌症治疗,但面临毒性问题.
- 迫切需要更安全,更有效的针对蛋白质稳定性的癌症治疗方法.
研究的目的:
- 探索HSP90抑制作为一种策略,通过调节蛋白质稳定来向癌症特征.
- 研究冷大气等离子体 (CAP) 作为具有减少不良影响的HSP90抑制剂的潜在替代品.
- 扩大HSP90抑制剂和CAP的治疗潜力,使其适用于由炎症驱动的疾病.
主要方法:
- 描述HSP90抑制剂在癌症特征进展中的作用.
- 质疑蛋白质稳定和氧化还原稳定之间的联系.
- 评估冷大气等离子体 (CAP) 作为一种治疗方式.
主要成果:
- 通过调节细胞蛋白质稳定,HSP90抑制有效地向多种癌症特性.
- 冷大气等离子体 (CAP) 成为HSP90抑制剂的有希望的替代品,副作用较少.
- 无论是HSP90抑制剂还是CAP,都显示出治疗与炎症和失败的蛋白质稳定相关的自身免疫疾病的潜力.
结论:
- 抑制HSP90是一种可行的策略,通过蛋白质稳定性调节,同时向关键的癌症特性.
- 冷大气等离子体 (CAP) 为癌症和与炎症有关的疾病提供了一种新的,更安全的治疗方法.
- 这些发现可能会重塑癌症治疗模式,并为管理蛋白质静止和与炎症相关的疾病提供新的途径.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
03:03mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
02:26Protein Networks
4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
01:13The Proteasome
1.6K
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.6K
02:18The Proteasome
10.0K
Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
10.0K
02:18The Proteasome
4.3K
4.3K